Rockwell Medical, Inc.
RMTI
Rank in Stocks
#24825
Rockwell Medical, Inc., together with its associated companies, operates as a... Rockwell Medical, Inc., together with its associated companies, operates as a biopharmaceutical firm specializing in treatments for chronic and end-stage kidney disease. The company provides a range of therapies and products aimed at addressing iron deficiency and supporting hemodialysis procedures, serving markets both within the United States and internationally. A key offering includes its Triferic line (Triferic Dialysate and Triferic AVNU), an innovative iron replacement therapy. This therapy is designed to replenish iron and maintain healthy hemoglobin levels in dialysis patients, notably without increasing existing iron stores. Beyond iron management, Rockwell Medical manufactures, sells, and distributes a comprehensive range of hemodialysis concentrates. These include various acid concentrates such as CitraPure (citric), Dri-Sate (dry), and RenalPure (liquid), alongside a dry acid concentrate mixer, and powder bicarbonate concentrates like RenalPure and SteriLyte. These crucial products are vital for sustaining life in dialysis patients by facilitating the removal of toxins and the replacement of essential nutrients in their bloodstream. The company further supplies ancillary items critical for hemodialysis procedures. This extensive catalog comprises blood tubing, fistula needles, dialyzers, pharmaceuticals, specialized component kits, dressings, cleaning agents, filtration salts, and other necessary provisions utilized by hemodialysis providers. Looking to the future, Rockwell Medical is actively developing additional therapeutic candidates. These include treatments for hospitalized individuals suffering from acute heart failure, as well as solutions for home infusion therapy, enabling patients to receive intravenous medications in a home setting. The company primarily serves medium and small-sized dialysis chains, as well as independent dialysis centers. Established in 1996, Rockwell Medical, Inc. maintains its corporate headquarters in Wixom, Michigan.
Share Price
$7.52
Last synced: 2026-11-09
Market Cap
$30.31M
Change (1 day)
-2.72%
Change (1 year)
-21.26%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Rockwell Medical, Inc. (RMTI)
Category
Healthcare
Operating Margin for Rockwell Medical, Inc. (RMTI)
Operating Margin as of November 2026 TTM: -6.52%
According to Rockwell Medical, Inc.'s latest financial reports, its current operating margin (TTM) is -6.52%. At the end of 2025 the company had an operating margin of -6.77%.
Operating Margin history for Rockwell Medical, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -6.52% | -3.69% |
| 2025 | -6.77% | -1,228.33% |
| 2024 | 0.60% | -107.52% |
| 2023 | -7.98% | -65.38% |
| 2022 | -23.05% | -52.94% |
| 2021 | -48.98% | 7.20% |
| 2020 | -45.69% | -17.85% |
| 2019 | -55.62% | 8.68% |
| 2018 | -51.18% | 13.13% |
| 2017 | -45.24% | 19.27% |
| 2016 | -37.93% | 39.04% |
| 2015 | -27.28% | -15.80% |
| 2014 | -32.40% | -63.94% |
| 2013 | -89.84% | -17.48% |
| 2012 | -108.87% | 145.81% |
| 2011 | -44.29% | 818.88% |
| 2010 | -4.82% | -51.90% |
| 2009 | -10.02% | -35.97% |
| 2008 | -15.65% | 86.75% |
| 2007 | -8.38% | -48.24% |
| 2006 | -16.19% | -3,338.00% |
| 2005 | 0.50% | -78.07% |
| 2004 | 2.28% | 80.95% |
| 2003 | 1.26% | -116.80% |
| 2002 | -7.50% | -53.07% |
| 2001 | -15.98% | 14.06% |
| 2000 | -14.01% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -102.98% |
DE
|
|
| 19.68% | -103.02% |
DE
|
|
| 13.26% | -102.03% |
JP
|
|
| 17.08% | -102.62% |
CH
|
|
| 14.92% | -102.29% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Rockwell Medical, Inc.'s operating margin
What is Rockwell Medical, Inc.'s operating margin?
Rockwell Medical, Inc.'s operating margin is -6.52%, as of Nov 2026.
What was Rockwell Medical, Inc.'s operating margin in 2025?
In 2025, Rockwell Medical, Inc.'s operating margin was -6.77%, compared with 0.60% in 2024.
How has Rockwell Medical, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Rockwell Medical, Inc.'s operating margin was highest in 2024 (0.60%) and lowest in 2021 (-48.98%).
How does Rockwell Medical, Inc.'s operating margin compare with similar companies?
Rockwell Medical, Inc.'s operating margin (-6.52%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.